A short treatment with the EHMT inhibitor UNC0642 not only ameliorates synaptic and behavioral deficits in both AD models [2,3], but also significantly reduces hyperphosphorylated tau in the P301S Tau AD mouse model [2]. Here, MAPT is linked to Alzheimer disease.